Abstract:Two major β-adrenergic receptor (βAR) subtypes, β1AR and β2AR, are expressed in mammalian heart with β1AR coupling to Gs and β2AR dually coupling to Gs and Gi proteins. In many types of chronic heart failure, myocardial contractile response to both β1AR and β2AR stimulation is severely impaired. The dysfunction of βAR signaling in failing hearts is largely attributable to an increase in Gi signaling, because disruption of the Gi signaling restores myocardial contractile response to β1AR as well as β2AR stimulation. However, the mechanism terminating the β2AR-Gi signaling remains elusive, while it has been shown activation of the Gi signaling is dependent on agonist stimulation and subsequent PKA-mediated phosphorylation of the receptor. Here we demonstrate that regulator of G protein signaling 2 (RGS2) is a primary terminator of the β2AR-Gi signaling. Specifically, prolonged absence of agonist stimulation for 24h impairs the β2AR-Gi signaling, resulting in enhanced β2AR- but not β1AR-mediated contractile response in cultured adult mouse cardiomyocytes. Increased β2AR contractile response is accompanied by a selective upregulation of RGS2 in the absence of alterations in other major cardiac RGS proteins (RGS3–5) or Gs, Gi or βAR subtypes. Administration of a βAR agonist, isoproterenol (ISO, 1.0 nM), prevents RGS2 upregulation and restores the β2AR-Gi signaling in cultured cells. Furthermore, RGS2 ablation, similar to βAR agonist stimulation, sustains the β2AR-Gi signaling in cultured cells, whereas adenoviral overexpression of RGS2 suppresses agonist-activated β2AR-Gi signaling in cardiomyocytes and HEK293 cells. These findings not only define RGS2 as a novel negative regulator of the β2AR-Gi signaling but also provide a potential novel target for the treatment of chronic heart failure.

The Core Domain of Rgs16 Retains G-Protein Binding and Gap Activity in Vitro, but is Not Functional in Vivo

GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain

Gαs-specific structural elements attenuate interactions with RGS proteins

Isolation and Expression Pattern of RGS21 Gene, a Novel RGS Member.

Status and trends of RGS16 based on data visualization analysis: A review

Palmitoylation of RGS20 affects Gα o -mediated signaling independent of its GAP activity

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Structure-function analysis of plant G-protein regulatory mechanisms identifies key Gα-RGS protein interactions

Structural organization of a major neuronal G protein regulator, the RGS7-Gβ5-R7BP complex

Functional analysis of seven regulators of G protein signaling (RGSs) in the nematode-trapping fungus Arthrobotrys oligospora

Isolation and characterization of a regulator of G protein signaling (RGS16) gene homologue in yellow grouper Epinephelus awoara

Heterotrimeric G protein signaling without GPCRs: the Gα-binding-and-activating (GBA) motif

RGS2 is a Primary Terminator of Β2-Adrenergic Receptor-Mediated Gi Signaling

A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors.

In-depth analysis of Gαs protein activity by probing different fluorescently labeled guanine nucleotides

Mammalian Rho GTPases: new insights into their functions from in vivo studies

Multiple roles for the cytoplasmic C-terminal domains of the yeast cell surface receptors Rgt2 and Snf3 in glucose sensing and signaling

Analysis of RhoA-binding Proteins Reveals an Interaction Domain Conserved in Heterotrimeric G Protein β Subunits and the Yeast Response Regulator Protein Skn7

Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors

Constitutive activation mechanism of a class C GPCR

RGS14 Regulation of Post-Synaptic Signaling and Spine Plasticity in Brain